Alogliptin + Pioglitazone
Composition
This formulation contains Alogliptin and Pioglitazone as active ingrediant
Indications
This combination Formulation is used to treat type 2 diabetes mellitus
Side effects
Common side effects may include weight gain, edema, headache, upper respiratory tract infection, and hypoglycemia.
Precautions
To be used cautiously in the patients having medical conditions like heart failure, liver disease, or bladder cancer.
Contraindications
Contraindicated in the patients with known hypersensitivity to alogliptin, pioglitazone, or any component of the formulation.
Dosage and administration
Once in a day
Countries
Worldwide
Available Forms
Tablets
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai